Abstract
Background: During the first months of COVID-19, the Gastroenterology, Hepatology and Nutrition service of the Hospital Sant Joan de Déu in Barcelona, a leading pediatric center in Spain, introduced a new model of non-face-to-face care. Objective: To evaluate the impact of telephone consultations compared to those conducted face-to-face on healthcare utilization. Methodology: Two main indicators of effectiveness are used: the degree of resolution (percentage of first telemedicine visits that did not generate any new visits in the following 4 and 12 months) and the average number of subsequent visits. A distinction was made between visits for general pathologies (less complex) and those for pathologies treated in monographic consultations (chronic or complex pathologies). Effectiveness at 4 and 12 months was also compared. Results: After 4 months from the first visit, the degree of resolution is lower in the first telemedicine visits than in face-to-face visits for both general pathologies and those of monographic agendas for chronic and complex pathologies. After twelve months, the first general telemedicine visits are less resolute than face-to-face visits, while the resolution rate is the same for chronic and complex pathology visits. Each telemedicine visit generates on average more visits than face-to-face visits. In the short term, 133.4% more in the case of general visits and 51.4% more in the case of chronic and complex visits. In the long term, general telemedicine visits generate 57.31% more visits, while no statistically significant difference is observed between chronic and complex face-to-face and telemedicine visits. Conclusion: The results of this study show that the resolution capacity of the non-face-to-face model in pediatric care in the pandemic context is generally lower and generates more successive visits than the face-to-face model. This lower performance of the telemedicine model should be counterbalanced with its advantages.
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference17 articles.
1. European Comission (2018). Market Study on Telemedicine, Publications Office of the European Union. Available online: https://ec.europa.eu/health/sites/default/files/ehealth/docs/2018_provision_marketstudy_telemedicine_en.pdf.
2. Telemedicine in Pediatrics: Systematic Review of Randomized Controlled Trials;Shah;JMIR Pediatr. Parent.,2021
3. Telemedicine: A systematic review of economic evaluations;Delgoshaei;Med. J. Islam. Repub. Iran,2017
4. Eze, N.D., Mateus, C., and Hashiguchi, T.C.O. (2020). Telemedicine in the OECD: An umbrella review of clinical and cost-effectiveness, patient experience and implementation. PLoS ONE, 15.
5. López Seguí, F., Franch Parella, J., Gironès García, X., Mendioroz Peña, J., García Cuyàs, F., Adroher Mas, C., García-Altés, A., and Vidal-Alaball, J. (2020). A Cost-Minimization Analysis of a Medical Record-based, Store and Forward and Provider-to-provider Telemedicine Compared to Usual Care in Catalonia: More Agile and Efficient, Especially for Users. Int. J. Environ. Res. Public Health, 17.